Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Cash from Operations (2021 - 2026)

HeartSciences (HSCS) has disclosed Cash from Operations for 5 consecutive years, with 2334266.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 6.9% year-over-year to 2334266.0, compared with a TTM value of 7498357.0 through Oct 2025, up 4.84%, and an annual FY2025 reading of 7412994.0, down 22.12% over the prior year.
  • Cash from Operations was 2334266.0 for Q4 2025 at HeartSciences, down from 1953367.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 717491.0 in Q3 2021 and bottomed at 2334266.0 in Q4 2025.
  • Average Cash from Operations over 5 years is 1510474.06, with a median of 1583701.5 recorded in 2024.
  • The sharpest move saw Cash from Operations plummeted 152.51% in 2022, then rose 22.89% in 2025.
  • Year by year, Cash from Operations stood at 768053.0 in 2021, then crashed by 40.63% to 1080141.0 in 2022, then grew by 8.51% to 988187.0 in 2023, then tumbled by 120.97% to 2183550.0 in 2024, then fell by 6.9% to 2334266.0 in 2025.
  • Business Quant data shows Cash from Operations for HSCS at 2334266.0 in Q4 2025, 1953367.0 in Q3 2025, and 1590640.0 in Q2 2025.